Zatine Cosmocon Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.12 Cr
- Satisfied Charges ₹ 1.13 M
- Revenue Growth 27.09%
- Profit Growth 13.96%
- Ebitda -49.08%
- Net Worth 31.60%
- Total Assets 39.49%
About Zatine Cosmocon Pharma
Zatine Cosmocon Pharma Private Limited (ZCPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 March 2016 (Eight years and ten months 24 days old ). Its registered office is in Dharwad, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.12 Cr. The company has closed loans amounting to ₹1.13 M, as per Ministry of Corporate Affairs (MCA) records.
Arati Hegde and Girish Hegde serve as directors at the Company.
Company Details
-
Location
Dharwad, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900KA2016PTC086979
-
Company No.
086979
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Mar 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
What products or services does Zatine Cosmocon Pharma Private Limited offer?
Zatine Cosmocon Pharma Private Limited offers a wide range of products and services, including Skin Care, Bath Essentials.
Who are the key members and board of directors at Zatine Cosmocon Pharma?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Arati Hegde | Director | 16-Mar-2016 | Current |
Girish Hegde | Director | 16-Mar-2016 | Current |
Financial Performance of Zatine Cosmocon Pharma.
Zatine Cosmocon Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 27.09% increase. The company also saw a substantial improvement in profitability, with a 13.96% increase in profit. The company's net worth Soared by an impressive increase of 31.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Zatine Cosmocon Pharma?
In 2021, Zatine Cosmocon Pharma had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹11.18 M
₹1.13 M
Charges Breakdown by Lending Institutions
- Karnataka Bank Ltd. : 1.12 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
02 Feb 2023 | Karnataka Bank Ltd. | ₹7.00 M | Open |
19 Feb 2020 | Karnataka Bank Ltd. | ₹2.18 M | Open |
19 Dec 2019 | Karnataka Bank Ltd. | ₹1.00 M | Open |
11 Jul 2017 | Karnataka Bank Ltd. | ₹1.00 M | Open |
14 Nov 2017 | Karnataka Bank Ltd. | ₹1.13 M | Satisfied |
How Many Employees Work at Zatine Cosmocon Pharma?
Unlock and access historical data on people associated with Zatine Cosmocon Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zatine Cosmocon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zatine Cosmocon Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.